An Interim Safety Analysis of Combination Stereotactic Ablative Body Radiotherapy (SABR) with Adjuvant Anti-PD1 Immunotherapy in Oligometastatic Renal Cell Carcinoma

被引：0

作者：

Siva, Shankar ^{[1
,2
,3
]}

Bressel, Mathias ^{[1
]}

Sandhu, Shahneen ^{[1
]}

Tran, Ben ^{[1
]}

Mooi, Jennifer ^{[1
]}

Lewin, Jeremy ^{[1
]}

Loi, Sherene ^{[1
,2
,3
]}

Toner, Guy ^{[1
,2
,3
]}

Moon, Daniel ^{[1
]}

Goad, Jeremy ^{[1
]}

Shaw, Mark ^{[1
]}

Chander, Sarat ^{[1
]}

Eade, Thomas ^{[4
]}

Guminksi, Alex ^{[4
]}

Dasantha, Jayamanne ^{[4
]}

Pryor, David ^{[5
]}

Cuff, Katherine ^{[5
]}

Wood, Simon ^{[5
]}

Lawrentschuk, Nathan ^{[1
]}

Murphy, Declan ^{[1
]}

机构：

[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[2] Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[3] Univ Melbourne, Melbourne, Vic, Australia

[4] Northern Sydney Canc Ctr, Sydney, NSW, Australia

[5] Princess Alexandra Hosp, Brisbane, Qld, Australia

来源：

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

abs19

引用

页码：31 / 31

页数：1

共 50 条

[31] The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
Onal, Cem
Hurmuz, Pervin
Guler, Ozan Cem
Yavas, Guler
Tilki, Burak
Oymak, Ezgi
Yavas, Cagdas
Ozyigit, Gokhan
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (08): : 1533 - 1541
[32] The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma
Cem Onal
Pervin Hurmuz
Ozan Cem Guler
Guler Yavas
Burak Tilki
Ezgi Oymak
Cagdas Yavas
Gokhan Ozyigit
Clinical and Translational Oncology, 2022, 24 : 1533 - 1541
[33] Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Yang Liu
Wen Long
Zhiling Zhang
Zitong Zhang
Lixin Mai
Sijuan Huang
Hui Han
Fangjian Zhou
Pei Dong
Liru He
World Journal of Urology, 2021, 39 : 4183 - 4190
[34] Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Liu, Yang
Long, Wen
Zhang, Zhiling
Zhang, Zitong
Mai, Lixin
Huang, Sijuan
Han, Hui
Zhou, Fangjian
Dong, Pei
He, Liru
WORLD JOURNAL OF UROLOGY, 2021, 39 (11) : 4183 - 4190
[35] Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma
Liu, Yang
Zhang, Zhiling
Liu, Ruiqi
Wei, Wensu
Zhang, Zitong
Mai, Lixin
Guo, Shengjie
Han, Hui
Zhou, Fangjian
He, Liru
Dong, Pei
RADIATION ONCOLOGY, 2021, 16 (01)
[36] Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma
Yang Liu
Zhiling Zhang
Ruiqi Liu
Wensu Wei
Zitong Zhang
Lixin Mai
Shengjie Guo
Hui Han
Fangjian Zhou
Liru He
Pei Dong
Radiation Oncology, 16
[37] Novel case of nephrocolic fistula secondary to stereotactic ablative body radiotherapy for clear cell renal cell carcinoma
Brinded, Alex
Tay, Yeng Kwang
Woods, Rodney
ANZ JOURNAL OF SURGERY, 2020, 90 (09) : 1800 - 1801
[38] The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma (vol 82, pg 613, 2022)
Ali, Muhammad
Mooi, Jennifer
Lawrentschuk, Nathan
McKay, Rana R.
Hannan, Raquibul
Lo, Simon S.
Hall, William A.
Siva, Shankar
EUROPEAN UROLOGY, 2022, 82 (05) : E152 - E152
[39] EARLY FINDINGS OF A PROSPECTIVE CLINICAL TRIAL OF STEREOTACTIC ABLATIVE BODY RADIOTHERAPY FOR PRIMARY RENAL CELL CARCINOMA
Siva, S.
Pham, D.
Kron, T.
Devereux, T.
Corcoran, N. M.
Bressel, M.
Brook, N.
Grills, R.
Foroudi, F.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 43 - 44
[40] MR-Guided Stereotactic Ablative Body Radiotherapy for Pancreatic Oligometastases from Renal Cell Carcinoma
van Vulpen, J. K.
Eijkelenkamp, H.
Wessels, F.
Mulder, S.
Meijer, G. J.
Intven, M. P. W.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E112 - E112

← 1 2 3 4 5 →